Background: Tungsten carbide nanoparticles are being explored for their use in the manufacture of hard metals. To develop nanoparticles for broad applications, potential risks to human health and the environment should be evaluated and taken into consideration. Objective: We aimed to assess the toxicity of well-characterized tungsten carbide (WC) and cobaltdoped tungsten carbide (WC-Co) nanoparticle suspensions in an array of mammalian cells. Methods: We examined acute toxicity of WC and of WC-Co (10% weight content Co) nanoparticles in different human cell lines (lung, skin, and colon) as well as in rat neuronal and glial cells (i.e., primary neuronal and astroglial cultures and the oligodendro cyte precursor cell line OLN-93). Furthermore, using electron microscopy, we assessed whether nanoparticles can be taken up by living cells. We chose these in vitro systems in order to evaluate for potential toxicity of the nanoparticles in different mammalian organs (i.e., lung, skin, intestine, and brain). Results: Chemical–physical characterization confirmed that WC as well as WC-Co nanoparticles with a mean particle size of 145 nm form stable suspensions in serum-containing cell culture media. WC nanoparticles were not acutely toxic to the studied cell lines. However, cytotoxicity became apparent when particles were doped with Co. The most sensitive were astrocytes and colon epithelial cells. Cytotoxicity of WC-Co nanoparticles was higher than expected based on the ionic Co content of the particles. Analysis by electron microscopy demonstrated presence of WC nanoparticles within mammalian cells. Conclusions: Our findings demonstrate that doping of WC nanoparticles with Co markedly increases their cytotoxic effect and that the presence of WC-Co in particulate form is essential to elicit this combinatorial effect.

It is becoming increasingly important to develop assessment criteria for the quality of nanoplastics studies. This study is an attempt to establish such criteria based on those developed for engineered nanomaterials, the GUIDEnano and DaNa criteria being two representatives. These criteria were applied to studies on polystyrene nanoparticles (PS NPs), which currently represent the majority of studies on nanoplastics. We compiled a list of existing nanomaterial-related criteria that are not fully relevant to PS NPs and propose additional nanoplastic-specific criteria targeting polymer chemical composition, source, production and field collection, impurities/chemical additives, density, hydrophobicity, colour, and chemical leaching. For each criterion, scientific justification is provided. We conclude that the existing study quality assessments originally developed for nano(eco)toxicity studies can, through refinements, be applied to those dealing with nanoplastics studies, with a further outlook on microplastics. The final quality criteria catalogue presented here is intended as a starting point for further elaborations considering different purposes of an assessment.